ClearPoint Neuro (CLPT) Short-term Investments (2022 - 2023)
ClearPoint Neuro recorded quarterly Short-term Investments of $9.9 million in Q1 2023, little changed quarter-over-quarter from $9.9 million in Q4 2022.
ClearPoint Neuro's Short-term Investments history runs 2 years deep, the most recent figure standing at $9.9 million for Q1 2023.
- In Q1 2023, Short-term Investments changed N/A year-over-year to $9.9 million; the TTM figure through Mar 2023 stood at $9.9 million (changed N/A YoY), while the FY2022 annual figure was $9.9 million, changed N/A from the prior year.
- Short-term Investments came in at $9.9 million for Q1 2023 at ClearPoint Neuro, roughly flat from $9.9 million in the prior quarter.
- In the past five years, Short-term Investments ranged from a high of $21.7 million in Q3 2022 to a low of $9.9 million in Q4 2022.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | ClearPoint Neuro | 375.84 Mn | 340.24 Mn | 7.76 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2023 | 9.94 Mn |
| Dec 31, 2022 | 9.90 Mn |
| Sep 30, 2022 | 21.75 Mn |
| Jun 30, 2022 | 21.60 Mn |